Which closed-end funds own Vaxcyte Inc?
5 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $23.1M. Security type: common equity. Country: United States. CUSIP 92243G108 · ISIN US92243G1085 · ticker PCVX.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors | Healthcare | 1.07% | $7.4M | 126,674 sh | $690M | 3.4% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.88% | $12M | 206,804 sh | $1.4B | 7.1% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.18% | $2M | 33,589 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.13% | $761K | 13,092 sh | $573M | 2.8% discount | Jun 30, 2026 |
| QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund | Covered Call / Option Income | 0.07% | $1M | 17,821 sh | $1.6B | 3.3% discount | Jun 30, 2026 |
5 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “PCVX” → · Compare two funds’ portfolios →